RxDoctor Payments Data

Terry Baker, MD

Otolaryngology · Idaho Falls, IDNPI 1568406148

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $151 and has fallen 63.8% since, to $55 in 2025. That places this record below the midpoint for otolaryngology clinicians in ID, where the typical reported total is $471.

$444in general payments, 2019–2025

Across 23 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$86
  • Boston Scientific$60
  • Stryker$59
  • Carestream Dental, LLC$43
  • Optinose US, Inc.$37
  • Medtronic$33
  • plus $128 from 7 others

What the payments were for

  • Food & beverage$444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$444 in reported general payments places this provider in the 45th percentile of 40 otolaryngology providers in Idaho.

See all otolaryngology providers in Idaho

Medicare billing

Part B allowed, 2024
$161,866
Medicare patients
362
Services billed
1,819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab21$76,654
Nurtec OdtRimegepant Sulfate13$15,485
Cefdinir75$4,106
Ipratropium Bromide127$3,483
Pilocarpine Hcl19$1,944
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$1,619
Omeprazole217$1,525
Levothyroxine Sodium201$1,359
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,096
Acetazolamide19$987
Ondansetron Hcl13$868
Liothyronine Sodium25$813
SynthroidLevothyroxine Sodium16$609
Fluticasone Propionate48$333
Famotidine38$320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$14$15,48513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 40 otolaryngology providers in Idaho.

Other otolaryngology in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →